Endometrial fluid associated with Essure implants placed before in vitro fertilization: Considerations for patient counseling and surgical management

Essure (Bayer) received approval from the U.S. Food and Drugs Administration as a permanent non-hormonal contraceptive implant in November 2002. While the use of Essure in the management of hydrosalpinx prior to in vitro fertilization (IVF) remains off-label, it has been used specifically for this p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sills, E Scott, Walsh, David J, Jones, Christopher A, Wood, Samuel H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Reproductive Medicine 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604296/
https://www.ncbi.nlm.nih.gov/pubmed/26473113
http://dx.doi.org/10.5653/cerm.2015.42.3.126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604296/
https://www.ncbi.nlm.nih.gov/pubmed/26473113
http://dx.doi.org/10.5653/cerm.2015.42.3.126

Ejemplares similares